Titomic Limited (ASX:TTT) Secures US$10.3 Million EXIM Loan for Alabama Cold Spray Expansion

Sonal Goyal

22 October 2026 12:09 PM AEDT

Titomic Limited (ASX:TTT) Secures US$10.3 Million EXIM Loan for Alabama Cold Spray Expansion

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

The Export-Import Bank of the United States approved a US$10.3 million (A$14.7 million) direct loan to Titomic USA, Inc.
Funds will buy an integrated high-pressure cold-spray production cell for the Huntsville, Alabama operation.
The financing sits under EXIM's Make More in America Initiative, aimed at export-oriented domestic manufacturing.
The transaction is expected to support at least dozens of new full-time jobs in Alabama.

Titomic Limited (ASX:TTT) has received approval from the Export-Import Bank of the United States (EXIM) for a direct loan of US$10.3 million, equivalent to A$14.7 million, to be extended to its subsidiary Titomic USA, Inc. The funding, which the company describes as supporting the expansion, is earmarked for the expansion of advanced manufacturing capabilities at Huntsville, Alabama, where the group maintains its global headquarters.

The announcement was issued from Huntsville on 21 October 2026 and published as an ASX release on 22 October 2026, with Titomic describing itself as a global advanced manufacturing business serving the United States and allied industrial base through its proprietary cold spray Titomic Kinetic Fusion (TKF) technology.

Loan Structure and Programme Backing

The loan has been approved under the Bank's Make More in America Initiative. That programme extends EXIM financing to export-oriented manufacturing projects located inside the United States, with particular attention to sectors regarded as critical to national security.

EXIM Chairman John Jovanovic said the initiative is intended to ensure that strategically important production capabilities, such as those operated by Titomic, remain in the United States for years to come. He added that the effort is strengthening the American advanced manufacturing base and supporting well-paying jobs.

The facility is described as a direct loan from the Bank to Titomic USA, which sits within the wider Titomic group listed on the ASX. The announcement does not set out the term, interest rate or repayment schedule of the facility, and those details were not provided alongside the approval.

What the Financing Will Buy

The proceeds will fund the purchase of an integrated high-pressure cold-spray production cell. Titomic said the equipment, once installed, will allow it to expand domestic capacity to manufacture, repair and restore high-performance metal components inside the United States.

Cold spray is the process at the centre of the company's offering. Titomic describes its Kinetic Fusion technology as patented and applies it to large integrated solutions for industrial-scale metal additive manufacturing, coating and repairs. Its production and research and development services are directed at customers in aerospace, defense, shipbuilding, oil and gas, mining and automotive industries.

The company also provides global sales and support for its cold spray additive manufacturing activities from the Huntsville headquarters, alongside a local presence in Australia and Europe.

Jobs, Local Leaders and Industrial Aims

The transaction is expected to support at least dozens of new full-time jobs in Alabama. Jim Simpson, Chief Executive Officer and Managing Director of Titomic, said EXIM's support marks an important milestone as the company expands United States manufacturing capacity, creates skilled American jobs and strengthens domestic supply chains for critical industries.

The member of Congress who represents Alabama's fifth district said the financing will support advanced manufacturing in North Alabama and help expand the country's industrial capabilities. He noted that the region has the workforce and expertise to lead in the field and that the aim is to keep building on that strength locally, in a state where the company already operates its global headquarters.

The announcement also lists several intended outcomes for the project. These include reducing reliance on overseas production, improving industrial resilience and supporting United States technological leadership in next-generation manufacturing. Huntsville is described in the announcement as a growing regional hub for aerospace and defense innovation, and the expanded operations are expected to contribute to a larger domestic industrial base and to export-oriented growth. Taken together, the stated objectives link a single equipment purchase to wider goals for domestic supply chains and national manufacturing capability.

Where the Approval Leaves Titomic

In summary, Titomic has secured a US$10.3 million direct loan from EXIM under its Make More in America Initiative, with the money directed to a single identifiable asset: an integrated high-pressure cold-spray production cell in Huntsville. The stated purpose is to widen the company's domestic capacity to manufacture, repair and restore metal components.

The release attaches a job-creation expectation of at least dozens of full-time positions in Alabama and ties the project to export-oriented growth. The terms of the loan, the timing of the equipment purchase and the financial effect on Titomic were not disclosed in the announcement, which was authorised for release by the company's Board of Directors.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.